Survival and differential co-expression data suggest that PER3 could be important modulating the relapse-free survival outcomes of LumA breast cancer patients by regulating cell cycle though mechanisms not fully elucidated that may involve loss of cell cycle control though decoupling of circadian function. Here, PER3 is linked to breast carcinoma.